|
|
Volumn 15, Issue SUPPL. 5, 2000, Pages 30-31
|
|
Management of disturbed calcium metabolism in uraemic patients: 3. Potential perspectives - Calcimimetics
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALUMINUM;
AMINOGLYCOSIDE;
CALCITONIN;
CALCITRIOL;
CALCIUM;
CALCIUM CHANNEL STIMULATING AGENT;
CALCIUM SENSING RECEPTOR;
GADOLINIUM;
GENTAMICIN;
MAGNESIUM;
NEOMYCIN;
NPS 563;
PARATHYROID HORMONE;
PARATHYROID HORMONE RECEPTOR;
PHENYLALKYLAMINE;
PHOSPHONIC ACID DERIVATIVE;
R 568;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CALCIUM METABOLISM;
CALCIUM TRANSPORT;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG MECHANISM;
DRUG POTENCY;
DRUG RECEPTOR BINDING;
DRUG SAFETY;
DRUG SELECTIVITY;
HUMAN;
HYPERCALCEMIA;
HYPERPARATHYROIDISM;
HYPOCALCEMIA;
INTESTINE ABSORPTION;
NEPHROTOXICITY;
NONHUMAN;
PARATHYROID HYPERPLASIA;
PRIORITY JOURNAL;
RAT;
UREMIA;
|
|
EID: 0033786775
PISSN: 09310509
EISSN: None
Source Type: Journal
DOI: 10.1093/ndt/15.suppl_5.30 Document Type: Article |
|
Times cited : (10)
|
|
References (10)
|
